Form 8-K - Current report:
SEC Accession No. 0001213900-14-004257
Filing Date
2014-06-17
Accepted
2014-06-17 08:01:10
Documents
2
Period of Report
2014-06-16
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8K f8k061614_immucell.htm 8-K 23731
2 FOURTH AMENDMENT TO RIGHTS AGREEMENT f8k061614ex4id_immucell.htm EX-4.1D 22434
  Complete submission text file 0001213900-14-004257.txt   47261
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 14924240
SIC: 2835 In Vitro & In Vivo Diagnostic Substances